Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

Published:2010 Issue:1 Volume:6 Page:34
ISSN:1744-9081
Container-title:Behavioral and Brain Functions
language:en
Short-container-title:Behavioral and Brain Functions

Author:

Wigal Timothy,Brams Matthew,Gasior Maria,Gao Joseph,Squires Liza,Giblin John,

Publisher

Springer Science and Business Media LLC

Subject

Behavioral Neuroscience,Biological Psychiatry,Cognitive Neuroscience,General Medicine

Reference25 articles.

1. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

2. Functional Impairments in Adults With Self-Reports of Diagnosed ADHD

3. A Simulated Workplace Experience for Nonmedicated Adults With and Without ADHD

4. Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorder

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine;Gynecologic Oncology;2024-11

2. Lisdexamfetamine’s Efficacy in Treating Attention Deficit Hyperactivity Disorder (ADHD): A Meta-Analysis and Review;Cureus;2024-08-31

3. Effects of Caffeine on Main Symptoms in Children with ADHD: A Systematic Review and Meta-Analysis of Randomized Trials;Brain Sciences;2023-09-11

4. The Use of Lisdexamfetamine to Treat ADHD in a Patient with Stimulant (Methamphetamine) Use Disorder;Case Reports in Psychiatry;2023-08-14

5. Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate;Journal of Attention Disorders;2023-05